Cosyntropin is the trade name, the generic name is scucizumab injection, this product needs to be used for a long period of time, in the condition of significant improvement can be considered after the discontinuation of the drug, do not need to be used all the time. Skuticosimab injection has the effect of inhibiting inflammatory cytokines, clinically, it is mainly used for patients with moderate to severe plaque psoriasis who meet the indications of phototherapy or systemic therapy. It requires regular long-term dosing, with weekly dosing for the first 5 weeks of use and every 4 weeks thereafter. Discontinuation may be considered when the condition improves markedly and does not require constant dosing. Adverse effects of this product include nasopharyngitis, oral herpes, runny nose, diarrhea, hives, etc. It is contraindicated in people who are allergic to this product and in people with severe active infections. Please follow the doctor’s instructions for regular administration of the drug, and regularly assess the condition to decide whether to stop the drug, do not discontinue the treatment on your own.